Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial
IC added to CRT does not adversely impact QoL compared to CRT, either during IC, during CRT or later.
Authors
- Madhavi Adusumalli
- Christopher Kent (ORCID: https://orcid.org/0000-0001-5634-9031)
- J. Forrest (ORCID: https://orcid.org/0000-0003-4141-822X)
- David Gallardo (ORCID: https://orcid.org/0000-0003-1615-4592)
- Mary McCormack (ORCID: https://orcid.org/0000-0002-8429-5744)
- A. Hackshaw
- T. Mathew
- Anjana Anand (ORCID: https://orcid.org/0000-0002-2856-4129)
- Gemma Eminowicz (ORCID: https://orcid.org/0000-0001-6514-808X)
- Jonathan A. Ledermann (ORCID: https://orcid.org/0000-0003-3799-3539)
- Anne-Marie Hacker
- A. Chan
- S. Vaja
- M. Panadés
Institutions
- University College Hospital (GB)
- Nottingham University Hospitals NHS Trust (GB)
- University of Leicester (GB)
- Royal Devon & Exeter NHS Foundation Trust (GB)
- Cancer Research UK (GB)
- University Hospitals of Leicester NHS Trust (GB)
- United Lincolnshire Hospitals NHS Trust (GB)
- South Tees Hospitals NHS Foundation Trust (GB)
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- Instituto Nacional de Cancerología (MX)
- University College London (GB)
Publication Details
- Journal
- European Journal of Cancer
- Published
- 2025-03-22
- DOI
- https://doi.org/10.1016/j.ejca.2025.115375
- Citations
- 4
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.23
Funders
- Cancer Research UK